CCL3 and breast cancer: Results from our breast cancer metastasis model suggest that the inhibition of CCL3 secretion from MAMs is one of the possible strategies as they are a major source of CCL3 among other leukocytes such as neutrophils, T, B, and NK cells in the metastatic lung [13].